Study on the cognition of sustained-released and controlled-release oral drugs in 400 diabetic patients contracted with general practitioners
10.3760/cma.j.cn115682-20191023-03824
- VernacularTitle:对400例家庭医生签约的糖尿病患者缓控释口服药物认知度的调查
- Author:
Jiexin GUO
1
;
Jingyu WANG
;
Jing DING
Author Information
1. 北京市通州区北苑街道社区卫生服务中心 101100
- Keywords:
Diabetes mellitus, type 2;
Contracting service with general practitioners;
Sustained-released and controlled-release oral drugs
- From:
Chinese Journal of Modern Nursing
2020;26(14):1884-1888
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the current cognition of sustained-released (SR) and controlled-release (CR) oral drugs in patients with type 2 diabetes mellitus (T2DM) who have been contracted with general practitioners, analyze the problems and causes in the patients' drug use, and put forward suggestions and countermeasures.Methods:Totally 400 T2DM patients using SR and CR oral drugs, who have been contracted with general practitioners from Yuetan Community Healthcare Center in Xicheng District and Xinhua Community Healthcare Center in Tongzhou District of Beijing were selected by convenient sampling in May 2019, and investigated with the self-designed SR and CR cognition questionnaire for T2DM patients. The patients' cognition and influencing factors of drug use were analyzed.Results:The correct answer rate of the six items in the SR and CR oral drug questionnaire among the 400 patients was 55.3%-59.3%. The correct answer rate of patients aged 41-60 years was higher than that of patients aged over 60 years; the correct answer rate of patients with higher educational levels was higher than that of patients with lower educational levels; and the correct rate of patients who met blood glucose standards was higher than that of patients who did not meet blood glucose standards, and the differences were statistically significant ( P < 0.01) . Conclusions:Diabetic patients contracted with general practitioners have a low level of understanding of SR and CR oral drugs. Individualized guidance based on the patients' own conditions is conducive to their cognition and correct use rate of SR and CR drugs.
